Skip to main content
Caplight Logo









Jiangsu Only Three Biotechnology Co., Ltd.

Jiangsu Only Three Biotechnology Co., Ltd.

Private
NanjingHealthcare & Life Scienceshttps://geneiii.com.cn/

Last Round

Early Funding

Jul 16, 2025

Est. Valuation

$84.21M

Total Funding Raised

$33.47M

Company Overview

Jiangsu Only Three Biotechnology Co., Ltd. is a synthetic biotechnology company that specializes in the research, development, production, and sales of bioactive raw materials, particularly ergothioneine, for the health and beauty industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, D2C Brands, E-commerce

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Non-AI

Keywords

L-ergothioneinesynthetic biologyfermentation platformdietary supplementsfunctional skincareantioxidantsynbioDTCdirect-to-consumerraw material supplierBacillus subtilisbio-manufacturingnutraceuticalscosmeceuticalsAI-assisted protein design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Jiangsu Only Three Biotechnology Co., Ltd. Comparables

Compare Jiangsu Only Three Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.

Jiangsu Only Three Biotechnology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Spec-Chem Industry Inc.
83%
Shanghai EGT Synbio Group Co., Ltd.
82%
Wuhan Hesheng Technology Co., Ltd.
79%

Jiangsu Only Three Biotechnology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJul 16, 2025
Early FundingApr 3, 2025
AngelJul 28, 2023

Jiangsu Only Three Biotechnology Co., Ltd. Investors

Notable investors and investment history

Jiangsu Only Three Biotechnology Co., Ltd. investors
InvestorRounds
Huayi CapitalEarly Funding
JAFCO AsiaEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 16, 2025

    $10M raised from Tuoxin Pharmaceutical Group

  • Apr 3, 2025

    $15M raised with JAFCO Asia leading the round.

Jiangsu Only Three Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Jiangsu Only Three Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Jiangsu Only Three Biotechnology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNanjing
Year Founded2021
Last FundingJul 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?